EP 0600973 A1 19940615 - A METHOD FOR TREATMENT OF METABOLIC DISORDERS AND METABOLISM.
Title (en)
A METHOD FOR TREATMENT OF METABOLIC DISORDERS AND METABOLISM.
Title (de)
VERFAHREN ZUR BEHANDLUNG VON STÖRUNGEN DES METABOLISMUS.
Title (fr)
PROCEDE DE TRAITEMENT DE TROUBLES METABOLIQUES ET DU METABOLISME.
Publication
Application
Priority
- US 9206536 W 19920811
- US 75005991 A 19910827
- US 75056991 A 19910827
Abstract (en)
[origin: WO9303714A2] A method for treating or preventing non-insulin (Type II) diabetes mellitus by administering to an animal, including humans, a compound selected from Table 1 or a pharmaceutically acceptable salt thereof; and a method for treating or preventing excess adiposity or obesity by administering to an animal, including humans, a compound selected from Table 2 or a pharmaceutically acceptable salt thereof.
Abstract (fr)
On décrit un procédé de traitement ou de prévention du diabète non-insulinodépendant (du Type II) par administration à un animal, y compris à l'homme, d'un composé sélectionné dans la Table 1 ou d'un sel pharmaceutiquement acceptable de celui-ci; on décrit également un procédé de traitement et de prévention de l'excès d'adiposité ou obésité par administration à un animal, y compris à l'homme, d'un composé sélectionné dans la Table 2 ou d'un sel pharmaceutiquement acceptable de celui-ci.
IPC 1-7
A61K 31/11; A61K 31/15; A61K 31/155; A61K 31/205; A61K 31/185; A61K 31/19; A61K 31/195; A61K 31/165
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/11 (2006.01); A61K 31/15 (2006.01); A61K 31/155 (2006.01); A61K 31/16 (2006.01); A61K 31/165 (2006.01); A61K 31/17 (2006.01); A61K 31/185 (2006.01); A61K 31/19 (2006.01); A61K 31/195 (2006.01); A61K 31/205 (2006.01); A61K 31/215 (2006.01); A61K 31/395 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/415 (2006.01); A61K 31/4184 (2006.01); A61K 31/42 (2006.01); A61K 31/44 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/4418 (2006.01); A61K 31/4425 (2006.01); A61K 31/4427 (2006.01); A61K 31/4433 (2006.01); A61K 31/445 (2006.01); A61K 31/454 (2006.01); A61K 31/455 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 31/535 (2006.01); A61K 31/5355 (2006.01); A61K 31/5375 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); C07D 209/14 (2006.01); C07D 213/73 (2006.01); C07D 213/80 (2006.01); C07D 231/12 (2006.01); C07D 233/56 (2006.01); C07D 235/30 (2006.01); C07D 239/60 (2006.01); C07D 277/20 (2006.01); C07D 277/22 (2006.01); C07D 277/34 (2006.01); C07D 279/04 (2006.01); C07D 279/18 (2006.01); C07D 295/20 (2006.01); C07D 401/06 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 409/04 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP US)
A61K 31/11 (2013.01 - EP); A61K 31/15 (2013.01 - EP); A61K 31/155 (2013.01 - EP); A61K 31/165 (2013.01 - EP); A61K 31/185 (2013.01 - EP); A61K 31/19 (2013.01 - EP); A61K 31/195 (2013.01 - EP); A61K 31/205 (2013.01 - EP); A61K 31/215 (2013.01 - EP); A61K 31/395 (2013.01 - EP US); A61K 31/40 (2013.01 - EP); A61K 31/405 (2013.01 - EP); A61K 31/415 (2013.01 - EP); A61K 31/44 (2013.01 - EP); A61K 31/445 (2013.01 - EP); A61K 31/455 (2013.01 - EP); A61K 31/47 (2013.01 - EP); A61K 31/495 (2013.01 - EP); A61K 31/505 (2013.01 - EP); A61K 31/535 (2013.01 - EP); A61P 3/08 (2017.12 - EP); A61P 3/10 (2017.12 - EP)
Citation (search report)
See references of WO 9303714A2
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9303714 A2 19930304; WO 9303714 A3 19930610; AU 2407592 A 19930316; AU 3061495 A 19951109; AU 3061595 A 19951109; AU 664710 B2 19951130; CA 2113817 A1 19930204; EP 0600973 A1 19940615; JP H06510760 A 19941201
DOCDB simple family (application)
US 9206536 W 19920811; AU 2407592 A 19920811; AU 3061495 A 19950914; AU 3061595 A 19950914; CA 2113817 A 19920811; EP 92917697 A 19920811; JP 50433693 A 19920811